Latest News

Home testing devices could monitor epilepsy, drug levels, reduce clinical visits

Medications remain the mainstay of epilepsy treatment, and to date there are no FDA-approved devices that provide an accurate means of detection for generalized tonic-clonic seizures (GTCS), or convulsions, during activities of daily living. Two new studies provide data that warrants the development of non-invasive devices with the capability to signal the onset of an epileptic seizure and could be crucial to optimal patient dosing.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Typically disregarded brain lesions may warn of heightened stroke risk

  • Nanomedicine in the fight against thrombotic diseases

  • Increased risk of complications, death during delivery for women with epilepsy

  • Cognitive behavioral therapy for insomnia with psychiatric, medical conditions

  • Reducing stroke damage may be next for optical coherence tomography technology widely used in vision healthcare

  • Restraint, confinement still an everyday practice in mental health settings

  • Age-related cognitive decline tied to immune-system molecule

  • New study again shows: More strokes with intracranial stents

  • People over 65 with traumatic brain injuries hospitalized four times as often as younger people

  • Uncovering the mechanism of our oldest anesthetic

  •